I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.

Journal Article

Improving the prognostic stratification of unresectable hepatocellular carcinoma (HCC) patients is critically needed. Since patients' survival is closely linked to the severity of the underlying liver disease, and insulin-like growth factor-1 (IGF-1) is produced predominantly in the liver, we hypothesized that IGF-1 may correlate with patients' survival and hence improve the prognostic ability of the Cancer of the Liver Italian Program (CLIP) score.Baseline plasma IGF-1 and clinicopathologic parameters were available from 288 patients. Multivariate Cox regression models, Kaplan-Meier curves, and the log-rank test were applied. Recursive partitioning was used to determine the optimal cut point for IGF-1 using training/validation samples. Prognostic ability of the I-CLIP (I = IGF) was compared to CLIP using C-index.IGF-1 significantly correlated with the clinicopathologic features. With an optimal IGF-1 cut point of 26 ng/ml, the overall survival of patients with IGF-1 >26 was 17.7 months (95% CI 13.6-22.8), and with IGF-1 ≤26 was 5.8 months (95% CI 4.0-12.5), p < 0.0001. The concordance probabilities for CLIP and I-CLIP were 0.7037 and 0.7096, respectively (p < 0.0001).Our preliminary results indicate that I-CLIP significantly improved prognostic stratification of patients with advanced HCC. However, independent validation of our study is warranted.

Full Text

Duke Authors

Cited Authors

  • Kaseb, AO; Abbruzzese, JL; Vauthey, J-N; Aloia, TA; Abdalla, EK; Hassan, MM; Lin, E; Xiao, L; El-Deeb, AS; Rashid, A; Morris, JS

Published Date

  • January 2011

Published In

Volume / Issue

  • 80 / 5-6

Start / End Page

  • 373 - 381

PubMed ID

  • 21822028

Electronic International Standard Serial Number (EISSN)

  • 1423-0232

International Standard Serial Number (ISSN)

  • 0030-2414

Digital Object Identifier (DOI)

  • 10.1159/000329040


  • eng